P. Lucas

Guidelines for the evaluation and treatment of muscle dysfunction in patients with chronic obstructive pulmonary disease.

J. Roca, E. Barreiro, J. Gea, 2015 .

Guidelines for the evaluation and treatment of muscle dysfunction in patients with chronic obstructive pulmonary disease.

J. Roca, E. Barreiro, J. Gea, 2015, Archivos de bronconeumologia.

Characteristics of COPD Patients Managed in Respiratory Medicine Departments in Spain, According to GOLD Groups and GesEPOC Clinical Phenotypes

M. Miravitlles, C. Esquinas, M. Calle, 2018, Archivos de Bronconeumología (English Edition).

“Correct Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease”: A Consensus Document

M. Miravitlles, C. Casanova, P. Lucas, 2015 .

Ethical Concerns of Congresses and Joint Winter Meetings of the Spanish Society of Pneumology and Thoracic Surgery

E. Chiner, E. Fernández-Fabrellas, P. Lucas, 2013 .

10 Years After EPISCAN: A New Study on the Prevalence of COPD in Spain—A Summary of the EPISCAN II Protocol

J. Soriano, M. Miravitlles, J. Ancochea, 2019, Archivos de Bronconeumología (English Edition).

Nasal continuous positive airway pressure in patients with COPD in acute respiratory failure. A study of the immediate effects.

P. Lucas, P. de Lucas, J. Monturiol, 1993, Chest.

Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (inmunoferón).

J. Izquierdo, M. Álvarez-Mon, J. Monserrat, 2001, American journal of respiratory and critical care medicine.

P atients with COPD have anabnormal respiratory

P. Lucas, J. Monturiol, E. Tatay, 2015 .